All stock lists
Unlock the score
Elite Pharmaceuticals Inc /Nv/ (OTC:ELTP)
US · Delayed Price · Currency is USD
Healthcare · Drug Manufacturers - Specialty & Generic
0.24-0.01 (-3.96%)
Insider Score
/ 100
ELTP Insider Score
ELITE PHARMACEUTICALS INC /NV/ has a live Insider Score.
Scored on 2 qualifying trades from 1 insider in the last 90 days.
ELTP Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 32.36 M | 40.75 M | 31.59 M | 36.32 M | 40.21 M | 32.00 M |
| Revenue Growth (YoY) | -19.54 % | 27.35 % | 119.92 % | 92.38 % | 113.85 % | 78.26 % |
| Cost of Revenue | 18.85 M | 20.35 M | 18.64 M | 22.25 M | 12.99 M | 14.70 M |
| Gross Profit | 13.51 M | 20.40 M | 12.95 M | 14.07 M | 27.23 M | 17.30 M |
| SG&A Expense | 3.55 M | 7.73 M | 2.47 M | 4.03 M | 3.46 M | 2.09 M |
| R&D Expense | 2.03 M | 1.64 M | 1.04 M | 1.39 M | 1.67 M | 2.04 M |
| Operating Expenses | 5.98 M | 9.37 M | 3.94 M | 5.86 M | 5.53 M | 6.14 M |
| Operating Income | 7.53 M | 11.03 M | 9.01 M | 8.21 M | 21.70 M | 11.15 M |
| Pretax Income | 7.72 M | 20.85 M | 20.83 M | 15.69 M | -564.21 K | 19.27 M |
| Tax Provision | 1.81 M | 2.39 M | 2.24 M | 1.99 M | 5.32 M | 2.27 M |
| Net Income | 5.91 M | 18.46 M | 18.59 M | 13.70 M | -5.88 M | 17.00 M |
| EPS (Basic) | 0.01 | 0.02 | 0.02 | 0.01 | -0.01 | 0.02 |
| EPS (Diluted) | 0.01 | 0.02 | 0.01 | 0.01 | -0.01 | 0.02 |
| Shares Outstanding | 1.08 B | 1.07 B | 1.07 B | 1.07 B | 1.07 B | 1.07 B |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.